Ethical Sample Collection
Discover how Synexa provides access to a range of human samples to translational research studies.
Translational Research Studies Utilising Fresh Human Biological Samples
Synexa’s clinical network is extensive; we collaborate with a wide range of clinicians who provide fresh (healthy and disease-matched) human biological samples from patients in support of clinical studies. Samples come with full clinical metadata – access well-characterised populations with disease-relevant heterogeneity.
Ethical integrity is the foundation of every translational research study we support. All patients provide informed consent, and we follow stringent national and international guidelines throughout. Our team manages the full ethics protocol development and submission process.
Oncology
Disease access:
- Acute Myeloid
- Leukaemia
- Chronic Lymphocytic Leukaemia
- Chronic myeloid leukaemia
- Non-Hodgkin’s lymphoma
- Hodgkin’s lymphoma
- Ovarian cancer
Sample matrices:
- Peripheral blood/PBMCs
- Serum & plasma
- Ascites
- Biopsies where possible
- Haematological
Neurology
Disease access:
- Multiple sclerosis
- Parkinson’s disease
- Alzheimer’s disease
- Neuroinflammatory conditions
- Neuropsychiatric conditions
Sample matrices:
- Peripheral blood/PBMCs
- Serum & plasma
- CSF where possible
- CNS-immune axis focus
Rheumatology
Disease access:
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Cutaneous lupus
- Psoriatic arthritis
- Myasthenia Gravis
Sample matrices:
- Peripheral blood/PBMCs
- Serum & plasma
- Urine
- Synovial fluid
- Tissue biopsies
Dermatology
Disease access:
- Atopic dermatitis
- Psoriasis
- Hidradenitis suppurativa
- Lichen planus
- Vitiligo
- Pemphigoid
Sample matrices:
- Fresh skin biopsies (lesional & non-lesional)
- Peripheral blood/PBMCs
- Serum & plasma
- Harpera microbiopsy
- Established skin biopsy workflows
Gastroenterology & Others
Disease access:
- IBD: Crohn’s and ulcerative colitis
- Fibrotic conditions
- Respiratory
Sample matrices:
- Peripheral blood/PBMCs
- Colon biopsies
- Serum & plasma
- Bronchoalveolar lavage fluid
- Active expansion
- Opthalmology
Ethical Patient Sample Collection
Meet a clinician from our extensive clinical network.
We collaborate with a diverse range of clinicians within our extensive clinical network to ethically source a broad range of samples and matrices that can be utilised for translational studies.
Learn why Professor Helmuth Reuter, Director of the Winelands Medical Research Centre and a renowned key opinion leader, partners with Synexa to help advance translational research and drug development.
See our ethical patient sampling process in action.
At Synexa, ethical integrity is the foundation of every clinical study we support. We approach informed consent with the care, clarity, and rigour required for international and multisite trials.
All patients provide their informed consent before participating in any study, allowing for multiple opportunities to ask questions and learn more about the clinical trial taking place. We follow stringent national and international guidelines to ensure the ethical integrity of each of our studies.
FAQs: Ethical Sample Collection and Patient Sample Access
How does Synexa source human biological samples for translational research?
Synexa works with an established global network of clinical partners to source ethically collected human biological samples. All samples are obtained in accordance with applicable local regulations, ethical approvals and informed consent requirements.
What sample types can Synexa provide?
Synexa can source a broad range of clinical sample matrices, including whole blood, serum, plasma, PBMCs, tissue specimens, cerebrospinal fluid (CSF), bronchoalveolar lavage fluid (BALF), urine and other disease-relevant biological materials.
Are all patient samples collected with informed consent?
Yes. Samples are only collected from donors who have provided informed consent, allowing their samples to be used for biomedical research. Consent procedures are managed by the originating clinical site or collection partner in accordance with local ethical and regulatory requirements.
Can Synexa provide samples from specific disease populations?
Yes. Through our global clinical network, Synexa can access samples from a wide range of disease areas, including oncology, immunology, infectious diseases, respiratory diseases, neurological disorders and rare diseases, subject to availability and ethical approval.
Improving the quality of human health
Contact us
Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline
